Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.